New MRI technique could make breast biopsy markers more visible

NCT ID NCT06873802

Completed Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a special MRI sequence called ZTE can show breast biopsy markers made of bone cement more clearly than standard metal markers. Twenty adults with breast cancer had MRI scans, and two radiologists rated how well the markers were seen. The goal is to improve follow-up imaging for breast cancer patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could improve how doctors see breast biopsy markers on MRI, potentially making follow-up scans clearer and safer.
What could go wrong: This is a small, completed imaging study with only 20 participants. It does not test a treatment, so any benefits are limited to better imaging, not disease outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CARCINOMA

Contacts and locations

Locations

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.